financetom
Business
financetom
/
Business
/
Hedge fund Millennium in talks to sell stake at $14 billion valuation, source says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Hedge fund Millennium in talks to sell stake at $14 billion valuation, source says
Jun 17, 2025 7:52 AM

LONDON, June 17 (Reuters) - Millennium Management is in

talks to sell a minority stake in its management company, in a

deal that values the hedge fund giant at $14 billion, said a

source with knowledge of the matter.

The company is working with Goldman Sachs' ( GS ) Petershill

Partners ( PHLLF ) to sell a stake of 10% to 15% to interested parties,

the source said.

Petershill ( PHLLF ), which buys minority stakes in asset managers, is

looking at placing part of the stake with its own clients and

part with others who already invest in Millennium's fund, the

source said, declining to name the investors.

Petershill ( PHLLF ) and Millennium declined to comment.

The Financial Times first reported the story.

Millennium, founded and led by billionaire Israel Englander,

manages more than $75 billion across a range of asset classes,

including equities, fixed income and commodities. The company

employs more than 6,200 people, according to its website.

Millennium's multi-strategy hedge fund returned a positive

1.7% return in May, bringing its investment performance to 0.4%

for 2025 to the end of May. Englander founded the hedge fund in

1989 with $35 million in capital.

Millennium has been exploring a stake sale for some time.

BlackRock ( BLK ), the world's largest asset manager, began

early-stage talks with Millennium about a strategic tie-up that

could involve buying a minority stake, Reuters reported in

November citing sources.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved